Nurses are voicing their concern about the lack of protective gear in caring patients with or suspected of having COVID-19; the FDA warned that new at-home tests in the marketplace for coronavirus disease, which is caused by severe acute respiratory syndrome coronavirus, have not been approved; US jails and prison systems have begun to allow the release of inmates who have commited petty crimes and those potentially at-risk of severe COVID-19 infection.
In a piece published by Kaiser Health News, nurses nationwide highlighted the need to lock up critical equipment, such as masks and respirators, as shortages of these gear leave many healthcare workers without ample protection of potential coronavirus (COVID-19) infection. Mary Mills, an intensive care nurse, noted the lack of communication during the pandemic as the guidance on when to use personal protective equipment keeps shifting daily. “What they decide I need, in terms of my safety, is being changed based on availability of product, rather than the science,” said Mills.With a number of at-home COVID-19 tests coming to the market, the FDA issued guidance to consumers that none of them has yet been approved for use and to be wary of fraudulent test kits, according to STAT. Experts indicated that the new tests may not meet the FDA’s high standards for traditional approval and that consumers risk not getting an accurate result if they don’t swab deep enough in their nose or throat. However, test manufacturers defended their at-home tests, insisting that they are permitted under government rules loosened to expand desperately needed testing for COVID-19.As the COVID-19 pandemic threatens to infect potentially at-risk inmates in US jails and prisons, officials have allowed expedited inmate releases for low-level crimes, according to Reuters. In New York City, which has become the epicenter for COVID-19, Mayor Bill de Blasio said yesterday that 23 inmates would be released before day’s end and the city would decide within 24 hours whether to release up to 200 more.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
2 Commerce Drive
Cranbury, NJ 08512